![Logo](/assets/logo-d3f1fdf60522f0983e71f9fcc720cb7da5b55c0b748ed5bded3d2fbf81387bf0.png)
PMC:7534795 / 57508-57897
Annnotations
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T406","span":{"begin":180,"end":188},"obj":"Disease"}],"attributes":[{"id":"A406","pred":"mondo_id","subj":"T406","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"In agreement with this idea, Torrinhas et al. suggested the immune modulatory properties of n-3 PUFAs will provide important and beneficial effects to improve clinical outcomes of COVID-19 particularly in hospitalized high-risk populations with severe underlying conditions including the elderly, obese, hypertensive, oncologic and diabetic patients (Torrinhas, Calder, \u0026 Waitzberg, 2020)."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T46084","span":{"begin":96,"end":101},"obj":"Chemical"}],"attributes":[{"id":"A60987","pred":"chebi_id","subj":"T46084","obj":"http://purl.obolibrary.org/obo/CHEBI_26208"}],"text":"In agreement with this idea, Torrinhas et al. suggested the immune modulatory properties of n-3 PUFAs will provide important and beneficial effects to improve clinical outcomes of COVID-19 particularly in hospitalized high-risk populations with severe underlying conditions including the elderly, obese, hypertensive, oncologic and diabetic patients (Torrinhas, Calder, \u0026 Waitzberg, 2020)."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T452","span":{"begin":0,"end":389},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In agreement with this idea, Torrinhas et al. suggested the immune modulatory properties of n-3 PUFAs will provide important and beneficial effects to improve clinical outcomes of COVID-19 particularly in hospitalized high-risk populations with severe underlying conditions including the elderly, obese, hypertensive, oncologic and diabetic patients (Torrinhas, Calder, \u0026 Waitzberg, 2020)."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1735","span":{"begin":341,"end":349},"obj":"Species"},{"id":"1739","span":{"begin":180,"end":188},"obj":"Disease"},{"id":"1740","span":{"begin":297,"end":302},"obj":"Disease"},{"id":"1741","span":{"begin":304,"end":316},"obj":"Disease"},{"id":"1742","span":{"begin":332,"end":340},"obj":"Disease"}],"attributes":[{"id":"A1735","pred":"tao:has_database_id","subj":"1735","obj":"Tax:9606"},{"id":"A1739","pred":"tao:has_database_id","subj":"1739","obj":"MESH:C000657245"},{"id":"A1740","pred":"tao:has_database_id","subj":"1740","obj":"MESH:D009765"},{"id":"A1741","pred":"tao:has_database_id","subj":"1741","obj":"MESH:D006973"},{"id":"A1742","pred":"tao:has_database_id","subj":"1742","obj":"MESH:D003920"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In agreement with this idea, Torrinhas et al. suggested the immune modulatory properties of n-3 PUFAs will provide important and beneficial effects to improve clinical outcomes of COVID-19 particularly in hospitalized high-risk populations with severe underlying conditions including the elderly, obese, hypertensive, oncologic and diabetic patients (Torrinhas, Calder, \u0026 Waitzberg, 2020)."}